2024 annual financial data
Summit Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -180,513,000 GBP and net income was -176,773,000 GBP.
Operating cash flow was -113,555,483 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 GBP
- Operating income
- -180,513,000 GBP
- Net income
- -176,773,000 GBP
- Operating cash flow
- -113,555,483 GBP